C12Y 204/01001
Phosphorylase
Official title: Phosphorylase (2.4.1.1)
C12Y204/01001 (Phosphorylase) appears on 26 US grants and 48 published applications in this corpus.
Search patents in C12Y- Granted patents
- 26
- Published applications
- 48
- Assignees
- 19
- Inventors
- 68
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 5 |
| 2020 | 4 | 5 |
| 2021 | 5 | 8 |
| 2022 | 5 | 5 |
| 2023 | 3 | 5 |
| 2024 | 2 | 9 |
| 2025 | 4 | 2 |
| 2026 | 2 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Enzymatic production of allulose15 Sep 2026US 12,735,685 B2Bonumose, Inc.
- Enzymatic production of hexoses24 Mar 2026US 12,584,121 B2Bonumose, Inc.
- Psicose-6-phosphate phosphatase, composition for producing psicose comprising the same, and method for producing psicose using the same20 May 2025US 12,305,203 B2Cj Cheiljedang Corporation
- Adeno-associated virus variant capsids and methods of use thereof11 Feb 2025US 12,221,616 B2AD Molecular Therapeutics Inc.
- Enzymatic production of hexoses4 Feb 2025US 12,215,371 B2Bonumose, Inc.
- Methods for producing alpha-cyclodextrins9 Jul 2026US 2026/0193686 A1Beren Therapeutics P.B.C.
- Compositions and methods for the production of 1,2-beta-oligoglucans19 Mar 2026US 2026/0078420 A1Cargill, Incorporated
- Methods for producing gamma-cyclodextrins5 Mar 2026US 2026/0062727 A1Beren Therapeutics P.B.C.
- Methods of altering the starch granule profile in plants12 Feb 2026US 2026/0043039 A1Plant Bioscience Limited
- Methods for producing beta-cyclodextrins29 Jan 2026US 2026/0028655 A1Beren Therapeutics P.B.C.
Most cited
By later US patents
- Adeno-associated virus variant capsids and methods of use thereof11US 11,118,192 B24D Molecular Therapeutics Inc. · 2021
- Method for enzymatically preparing highly concentrated myo-inositol2US 10,752,888 B2Cj Cheiljedang Corporation · 2020
- Enzymatic production of D-allulose2US 11,053,528 B2Bonumose, Inc. · 2021
- Adeno-associated virus variant capsids and methods of use thereof2US 11,613,766 B24 Molecular Therapeutics Inc. · 2023
- Enzymatic production of D-allulose1US 10,704,069 B2Bonumose, Inc. · 2020